title: Imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla OXA-23,51 and ISAba1-bla ADC-7 genes in Monteria, Colombia.
abstract: The purpose of this study was to identify the genes coding for resistance to ceftazidime and imipenem and describe the molecular epidemiology of A. baumannii strains isolated from a clinical center in Colombia. Twenty isolates of imipenem-resistant A. baumannii from an equal number of patients with nosocomial infections were obtained. Primers were used to amplify genes bla IMP, bla VIM, bla OXA-23, bla OXA-24, bla OXA-58, bla OXA-51 and bla ADC-7. To detect insertion sequences ISAba1/bla OXA-23, ISAba1/bla OXA-51 and ISAba1/bla ADC-7, mapping by PCR using combinations of reverse primers ISAba1 and reverse primers of bla OXA-23, bla OXA-51 and bla ADC-7 were used. The amplification products were purified and cloned into PCR 2.1-TOPO vector and transformed into chemically competent Escherichia coli TOP10. These amplicons were then sequenced. PFGE was performed on DNA of A. baumannii isolates digested with ApaI. Results. The DNA profiles obtained included 9 clusters with, four 2-7 isolates per profile, and 5 single-isolate profiles. Of the 20 isolates resistant to imipenem, 15 carried bla OXA-23 gene, 4 contained ISAba1 upstream of bla OXA-51 gene, and 6 contained ISAba1 upstream of bla OXA-23 gene. Eighteen of these isolates carried the bla ADC-7 gene, with 9 of the isolates having ISAba1 located upstream of this gene. This is the first report of the ISAba1/ADC-7 associated with OXAs genes in A. baumannii isolates from Colombia.
authors.affiliation: Universidad de Córdoba. Instituto de Investigaciones Biológicas del Trópico , Montería , Colombia.
authors.forename: Pedro
authors.initials: P
authors.lastname: Martínez
authors.forename: Salim
authors.initials: S
authors.lastname: Mattar
keywords: Antimicrobial resistance; Nosocomial pathogens; PFGE
references.citation: Int J Antimicrob Agents. 2006 Apr;27(4):351-3
references.pmid: 16564159
references.citation: J Antimicrob Chemother. 2005 Dec;56(6):1019-24
references.pmid: 16239286
references.citation: Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
references.pmid: 17630334
references.citation: Antimicrob Agents Chemother. 2001 Aug;45(8):2224-8
references.pmid: 11451678
references.citation: Lancet. 1994 Nov 12;344(8933):1329-32
references.pmid: 7968028
references.citation: J Hosp Infect. 2004 Nov;58(3):170-9
references.pmid: 15501330
references.citation: Antimicrob Agents Chemother. 2007 Jun;51(6):2001-4
references.pmid: 17403994
references.citation: J Antimicrob Chemother. 2003 Mar;51(3):565-74
references.pmid: 12615856
references.citation: Clin Microbiol Infect. 2006 Feb;12(2):123-30
references.pmid: 16441449
references.citation: J Clin Microbiol. 1995 Sep;33(9):2233-9
references.pmid: 7494007
references.citation: J Antimicrob Chemother. 2003 Oct;52(4):629-35
references.pmid: 12951337
references.citation: J Clin Microbiol. 2005 Sep;43(9):4328-35
references.pmid: 16145073
references.citation: Antimicrob Agents Chemother. 2005 Jul;49(7):2941-8
references.pmid: 15980372
references.citation: FEMS Microbiol Lett. 2006 May;258(1):72-7
references.pmid: 16630258
references.citation: Infect Dis Clin North Am. 2000 Mar;14(1):67-81, viii
references.pmid: 10738673
references.citation: Braz J Microbiol. 2009 Apr;40(2):339-41
references.pmid: 24031369
references.citation: Antimicrob Agents Chemother. 2005 May;49(5):1708-13
references.pmid: 15855485
references.citation: Antimicrob Agents Chemother. 2005 Jan;49(1):202-8
references.pmid: 15616297
references.citation: Clin Infect Dis. 1996 Sep;23(3):538-42
references.pmid: 8879777
references.citation: Antimicrob Agents Chemother. 2004 Feb;48(2):612-4
references.pmid: 14742218
references.citation: Clin Infect Dis. 2001 Oct 1;33(7):939-46
references.pmid: 11528563
references.citation: Clin Microbiol Infect. 2007 Dec;13(12):1192-8
references.pmid: 17850347
references.citation: J Clin Microbiol. 2003 Jul;41(7):3403-6
references.pmid: 12843104
references.citation: J Antimicrob Chemother. 1996 Dec;38(6):1114-5
references.pmid: 9023666
references.citation: FEMS Microbiol Lett. 2007 Sep;274(1):63-6
references.pmid: 17610514
references.citation: Antimicrob Agents Chemother. 2005 Dec;49(12):4876-83
references.pmid: 16304148
references.citation: FEMS Microbiol Lett. 2005 Feb 15;243(2):425-9
references.pmid: 15686845
references.citation: Curr Opin Investig Drugs. 2002 Feb;3(2):218-24
references.pmid: 12020049
references.citation: Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
references.pmid: 7984417
references.citation: J Mol Biol. 1990 Oct 5;215(3):403-10
references.pmid: 2231712
references.citation: Braz J Microbiol. 2011 Apr;42(2):415-22
references.pmid: 24031648